DoD Drug Demand Reduction Program PED and Steroid Testing - Sole Source Notice N0018925RZ094
Summary
AI-generated · Aug 24, 2025Laboratory testing in the continental United States (CONUS) for anabolic steroids and other performance-enhancing drugs listed in Classes S1, S2, and S4 of the World Anti-Doping Code Prohibited List, on human urine specimens, to support the DoD Drug Demand Reduction Program (DDRP). The contractor shall furnish all labor, equipment, materials, and facilities and perform testing in accordance with the forensic and scientific specifications of the World Anti-Doping Agency (WADAC) and the DoD DDRP Instructions.
This is a sole-source procurement; the Justification and Authority to solicit on a sole-source basis is attached to this notice.
This is a solicitation for laboratory testing in the continental United States (CONUS) for steroid and performance-enhancing drugs in support of the DoD Drug Demand Reduction Program (DDRP). The contractor shall furnish all labor, equipment, materials, and facilities to perform anabolic steroid and other Performance Enhancing Drugs (PEDs) explicitly listed in Classes S1, S2 and S4 of the World Anti-Doping Code Prohibited List testing on human urine specimens under the forensic and scientific specifications of the WADAC and the DOD DDRP Instructions. The Justification and Authority to solicit on a sole-source basis is attached to this notice.
From Combined Synopsis/Solicitation posted on Aug 22, 2025Notice history
1-
Combined Synopsis/Solicitation LATEST Posted Aug 22, 2025
Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA